Heidi Health secures 65M Series B funding for AI medical scribe

Heidi Health, an AI-powered medical scribe startup, has secured $65 million in a Series B funding round led by Steve Cohen’s Point72 Private Investments. The funding will accelerate product development and expand the company’s mission to reduce administrative burdens for healthcare providers worldwide.

Founding Vision and Product

Co-founded in 2021 by Dr. Tom Kelly, a trauma surgeon, and Waleed Mussa, Heidi Health aims to empower clinicians by automating administrative tasks. The platform includes features like:

• AI transcription and dictation for clinical notes
• Personalized patient summaries
• Task tracking to replace sticky notes

The company leverages a model-agnostic AI approach, combining proprietary models with third-party solutions like Google’s Gemini, optimizing accuracy and cost.

Growth and Adoption

Since launching products in early 2024, Heidi claims to have:

• Saved 18 million hours for healthcare providers
• Processed 70 million patient visits across 116 countries
• Engaged over 2 million clinicians weekly

The platform offers a freemium model, which Dr. Kelly credits for driving rapid adoption.

Funding and New Developments

The $65M Series B brings Heidi’s total funding to $96.6 million. Other investors include:

• Goodwater Capital
• Headline
• Blackbird VC
• LG Technology Ventures
• Alumni Ventures

Alongside the funding, Heidi unveiled a new AI agent capable of calling patients on behalf of doctors. The company also onboarded Dr. Simon Kos, former Chief Medical Officer at Microsoft, and Paul Williamson, Plaid’s head of revenue.

Dr. Kelly emphasized Heidi’s user-centric approach, contrasting it with competitors focused on top-down sales.

Future Vision

Heidi aims to democratize healthcare access, particularly in underserved regions:

• War zones
• Refugee camps
• Climate-affected areas